ResearcherNational Yang Ming Chiao Tung UniversityActive in the last 2 years
Yuan‐Hung Wu
Matched on ORCID iD 0000-0003-2908-7704; OpenAlex author ID A5006767938. Sources: OpenAlex.
Their work
- Papers
- 4
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 12
2022: 1 paper · 2023: none · 2024: 1 paper · 2025: none · 2026: 2 papers
Papers 4
- Concurrent Systemic Therapy Intensity and Metabolic Response in Carbon-Ion Radiation Therapy for Locally Advanced Pancreatic Cancer. Co-author DOI 10.1016/j.ijrobp.2026.09.005↗
- Carbon ion therapy for pancreatic cancer with risk-adapted dose escalation: initial clinical experience. Co-author DOI 10.1016/j.radonc.2025.111238↗
- Feasibility estimation of injected hydrodissection before definitive radiotherapy of pancreatic adenocarcinoma. Co-author DOI 10.1097/jcma.0000000000001084↗
- Correlation between drug sensitivity profiles of circulating tumour cell-derived organoids and clinical treatment response in patients with pancreatic ductal a… Co-author DOI 10.1016/j.ejca.2022.01.030↗
Closest collaborators
The 12 strongest of 12 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Chung‐Pin Li · 4 shared papers, 2022–2026 · strength 0.79
- Paper Concurrent Systemic Therapy Intensity and Metabolic Response in Carbon-Ion Radiation Therapy for Locally Advanced Pancr… DOI 10.1016/j.ijrobp.2026.09.005↗
- Paper Carbon ion therapy for pancreatic cancer with risk-adapted dose escalation: initial clinical experience. DOI 10.1016/j.radonc.2025.111238↗
- Paper Feasibility estimation of injected hydrodissection before definitive radiotherapy of pancreatic adenocarcinoma. DOI 10.1097/jcma.0000000000001084↗
- Keng-Li Lan · 3 shared papers, 2024–2026 · strength 0.68
- Paper Concurrent Systemic Therapy Intensity and Metabolic Response in Carbon-Ion Radiation Therapy for Locally Advanced Pancr… DOI 10.1016/j.ijrobp.2026.09.005↗
- Paper Carbon ion therapy for pancreatic cancer with risk-adapted dose escalation: initial clinical experience. DOI 10.1016/j.radonc.2025.111238↗
- Paper Feasibility estimation of injected hydrodissection before definitive radiotherapy of pancreatic adenocarcinoma. DOI 10.1097/jcma.0000000000001084↗
- Nai‐Jung Chiang · 2 shared papers, 2026 · strength 0.49
- Paper Concurrent Systemic Therapy Intensity and Metabolic Response in Carbon-Ion Radiation Therapy for Locally Advanced Pancr… DOI 10.1016/j.ijrobp.2026.09.005↗
- Paper Carbon ion therapy for pancreatic cancer with risk-adapted dose escalation: initial clinical experience. DOI 10.1016/j.radonc.2025.111238↗
- I‐Chun Lai · 2 shared papers, 2026 · strength 0.49
- Paper Concurrent Systemic Therapy Intensity and Metabolic Response in Carbon-Ion Radiation Therapy for Locally Advanced Pancr… DOI 10.1016/j.ijrobp.2026.09.005↗
- Paper Carbon ion therapy for pancreatic cancer with risk-adapted dose escalation: initial clinical experience. DOI 10.1016/j.radonc.2025.111238↗
- Yu‐Wen Hu · 2 shared papers, 2024–2026 · strength 0.42
- Shih‐Ming Hsu · 2 shared papers, 2022–2024 · strength 0.30
- Paper Feasibility estimation of injected hydrodissection before definitive radiotherapy of pancreatic adenocarcinoma. DOI 10.1097/jcma.0000000000001084↗
- Paper Correlation between drug sensitivity profiles of circulating tumour cell-derived organoids and clinical treatment respo… DOI 10.1016/j.ejca.2022.01.030↗
- I‐Wei Ho · 1 shared paper, 2026 · strength 0.26
- Hung-Yuan Yu · 1 shared paper, 2026 · strength 0.23
- Minghuang Chen · 1 shared paper, 2026 · strength 0.23
- Shin‐E Wang · 1 shared paper, 2022 · strength 0.11
- Long‐Sheng Lu · 1 shared paper, 2022 · strength 0.11
- Yee Chao · 1 shared paper, 2022 · strength 0.11
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.